Autoimmune Injectables to 2020

DUBLIN, Dec. 11, 2014 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/6pxbmd/autoimmune) has announced the addition of the "Autoimmune Injectables to 2020" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

In spite of the growing understanding of the underlying disease mechanisms for a host of diseases and disease families, autoimmune conditions continue to be intractable to most therapies and difficult to treat. Because of the individual genetic variability underlying the incidence and severity of autoimmune symptoms, regional variations in the market for autoimmune therapeutics can be significant.

This variability is compounded by differences in treatment protocols and cultural factors, which combine to make alliance partnerships with regional players of increasing importance. Over the past two years the introduction of new and improved injectables for treating autoimmune diseases is creating new options for clinicians and patients. This optimism is being reinforced by pipeline candidates that will further the effort to improve treatment protocols for patients.

Highlights

• Analyzes current therapeutic options for autoimmune diseases, and evaluates emerging therapeutic candidates and assesses their commercial potential
• Assesses existing and evolving immune disease mechanisms, treatment strategies and pipeline drug candidates
• Provides data and forecasts for major autoimmune disease segments to 2020
• Evaluates regional and global opportunities for autoimmune therapeutics

Key Topics Covered:

Executive Summary

Immune Modulation in Disease Therapeutics

• Evolving Models of Disease and Human Health
• The Immune Response in Disease Incidence, Treatment & Prevention
• The Immune Cascade
• Receptors, Ligands and Cell Signaling Pathways

Autoimmune Disease Therapeutics- Commercial Realities

• FDA-Approved Drugs
• Patient and Disease Demographics
• Competitive Landscape
• Factors Limiting Growth
• Regulatory Factors
• Cost per Dose and Managed Care
• Side Effects, Black Box Warnings and Patient Compliance

Autoimmune Disease Therapeutics - Disease Segment Analysis

• Arthritis
• Psoriasis
• Multiple Sclerosis
• Crohn's Disease
• Lupus

Autoimmune Injectables - Indications, Market Data and Forecasts

• TNF
• Growth Factor inhibitors
• Interleukins
• Interferons
• T-Cell Receptor Inhibitors
• Innate Immune Cell Receptor Inhibitors
• B-Cell Receptor Inhibitors
• Kinase Inhibitors
• Co-stimulator Inhibitors
• Chemokine Receptors
• Transcription Factors
• Vascular Adhesion Inhibitors
• Toll-like Receptors
• Other Immune Factor Drug Candidates

Business Factors

• Regulatory Factors
• Clinical Trial Protocols & Endpoints
• Alliances and Partnerships

Autoimmune Injectables Company Profile

For more information visit http://www.researchandmarkets.com/research/6pxbmd/autoimmune

Media Contact:

Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets